JP2019514913A5 - - Google Patents

Download PDF

Info

Publication number
JP2019514913A5
JP2019514913A5 JP2018556332A JP2018556332A JP2019514913A5 JP 2019514913 A5 JP2019514913 A5 JP 2019514913A5 JP 2018556332 A JP2018556332 A JP 2018556332A JP 2018556332 A JP2018556332 A JP 2018556332A JP 2019514913 A5 JP2019514913 A5 JP 2019514913A5
Authority
JP
Japan
Prior art keywords
agent
optionally
polypeptide
antibody
adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018556332A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019514913A (ja
JP7160683B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/030454 external-priority patent/WO2017190148A1/en
Publication of JP2019514913A publication Critical patent/JP2019514913A/ja
Publication of JP2019514913A5 publication Critical patent/JP2019514913A5/ja
Application granted granted Critical
Publication of JP7160683B2 publication Critical patent/JP7160683B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018556332A 2016-04-29 2017-05-01 術後癒着の予防及び治療のための方法及び組成物 Active JP7160683B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662329666P 2016-04-29 2016-04-29
US62/329,666 2016-04-29
PCT/US2017/030454 WO2017190148A1 (en) 2016-04-29 2017-05-01 Methods and compositions for the prevention and treatment of surgical adhesions

Publications (3)

Publication Number Publication Date
JP2019514913A JP2019514913A (ja) 2019-06-06
JP2019514913A5 true JP2019514913A5 (enExample) 2020-05-28
JP7160683B2 JP7160683B2 (ja) 2022-10-25

Family

ID=60161169

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018556332A Active JP7160683B2 (ja) 2016-04-29 2017-05-01 術後癒着の予防及び治療のための方法及び組成物

Country Status (9)

Country Link
US (1) US10934355B2 (enExample)
EP (1) EP3448421B1 (enExample)
JP (1) JP7160683B2 (enExample)
CA (1) CA3019841A1 (enExample)
ES (1) ES2903210T3 (enExample)
PL (1) PL3448421T3 (enExample)
PT (1) PT3448421T (enExample)
SI (1) SI3448421T1 (enExample)
WO (1) WO2017190148A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108795867A (zh) * 2018-06-05 2018-11-13 华东理工大学 用于构建结肠癌细胞腹膜转移体外三维模型的方法
US11591390B2 (en) 2018-09-27 2023-02-28 Celgene Corporation SIRP-α binding proteins and methods of use thereof
BR112021005585A2 (pt) 2018-09-27 2021-06-29 Celgene Corporation proteínas de ligação a sirpa e métodos de uso das mesmas
US20220125754A1 (en) 2019-01-29 2022-04-28 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Treating the causative agent in adhesiogenesis
US20200386772A1 (en) * 2019-06-05 2020-12-10 Mark D. Noar Method For Detecting Bodily Adhesions By Identifying Markers In Circulating Cells
US20230293457A1 (en) * 2020-02-26 2023-09-21 Shanghaitech University Application of disulfiram in coronavirus resistance
CA3202048A1 (en) * 2020-12-14 2022-06-23 Joel ZINDEL Treatment of peritoneal, pleural, and pericardium adhesions
US12440285B2 (en) 2021-01-22 2025-10-14 Cilag Gmbh International Prediction of hemostasis issues based on biomarker monitoring
US20220233135A1 (en) * 2021-01-22 2022-07-28 Ethicon Llc Prediction of adhesions based on biomarker monitoring
US12011163B2 (en) 2021-01-22 2024-06-18 Cilag Gmbh International Prediction of tissue irregularities based on biomarker monitoring
CN113244400B (zh) * 2021-05-21 2022-12-16 华北理工大学 一种C5aRA在制备治疗和/或预防腹腔粘连的产品中的应用
EP4426718A1 (en) * 2021-11-05 2024-09-11 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH Modulators of mesothelial ecm movement

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985660A (en) 1994-06-15 1999-11-16 Systemix, Inc. Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
US5639468A (en) * 1995-06-07 1997-06-17 University Of Southern California Method for reducing or preventing post-surgical adhesion formation using manoalide and analogs thereof
DE69805316T2 (de) 1997-10-16 2002-12-05 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno, Delft Vorbeugung und behandlung von adhäsionbildung
US6812220B2 (en) 2001-08-29 2004-11-02 University Of British Columbia Pharmaceutical compositions and methods relating to fucans
EP1482975B1 (en) * 2002-01-29 2006-12-13 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Prevention of tissue adhesion
US20040131600A1 (en) * 2002-03-11 2004-07-08 Diamond Michael P. Method of preventing adhesions by apoptosis of adhesion peritoneal cells
JP4224586B2 (ja) 2004-04-28 2009-02-18 国立大学法人群馬大学 マクロファージ活性化剤並びにその製造方法及びスクリーニング方法
US20080045463A1 (en) * 2004-10-25 2008-02-21 Ajay Verma Methods For Lowering Hif-1 Mediated Gene Expression
ES2429340T3 (es) * 2005-03-10 2013-11-14 Morphotek, Inc. Anticuerpos anti-mesotelina
US9505867B2 (en) * 2005-05-31 2016-11-29 Ecole Polytechmique Fédérale De Lausanne Triblock copolymers for cytoplasmic delivery of gene-based drugs
AU2006279218B2 (en) 2005-08-11 2013-05-02 Adetherapeutics, Inc. Reducing post-operative adhesion formation with intraperitoneal glutamine
WO2008011726A1 (en) 2006-07-27 2008-01-31 Ottawa Health Research Institute Staged immune-response modulation in oncolytic therapy
KR101554753B1 (ko) * 2007-10-01 2015-09-22 브리스톨-마이어스 스큅 컴퍼니 메소텔린에 결합하는 인간 항체 및 이의 용도
PT3056515T (pt) 2008-01-15 2019-07-19 Univ Leland Stanford Junior Métodos para manipulação da fagocitose mediada por cd47
ES2325724B1 (es) * 2008-03-11 2010-05-31 FUNDACION DE LA COMUNIDAD VALENCIANA "CENTRO DE INVESTIGACIONES PRINCIPE FELIPE" Composicion farmaceutica para inhibir el factor de transcripcion inducible por hipoxia. moduladores de procesos patologicos de angiogenesis, oncogenesis, inflamacion, apoptosis y terapia celular.
AU2010230063B2 (en) * 2009-03-24 2015-06-25 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Anti-mesothelin antibodies
CA2771336C (en) 2009-09-15 2019-11-26 The Board Of Trustees Of The Leland Stanford Junior University Synergistic anti-cd47 therapy for hematologic cancers
JP2011195574A (ja) * 2010-02-25 2011-10-06 Kwansei Gakuin ビスフェノールa誘導体を含有するhif阻害剤
EP3766511A1 (en) 2012-01-17 2021-01-20 The Board of Trustees of the Leland Stanford Junior University High affinity sirp-alpha reagents
US8962577B2 (en) * 2012-03-16 2015-02-24 The Johns Hopkins University Controlled release formulations for the delivery of HIF-1 inhibitors
JP6426693B2 (ja) 2013-03-15 2018-11-21 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 抗cd47薬の処理上有効量を達成するための方法

Similar Documents

Publication Publication Date Title
JP2019514913A5 (enExample)
Tripathi et al. HMGB1 protein as a novel target for cancer
JP2006525796A5 (enExample)
Kobayashi Neutrophil infiltration and chemokines
Wiersinga et al. Host innate immune responses to sepsis
EP3448421B1 (en) Methods and compositions for the prevention and treatment of surgical adhesions
Bauditz et al. Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease.
JP6222749B2 (ja) 医薬組成物及びその使用
JP2011519277A5 (enExample)
WO2018187740A1 (en) Bioorthogonal compositions
JP2013100314A5 (enExample)
JP2012522508A5 (enExample)
Atluri et al. Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder
Grist et al. Neutrophils and viral-induced neurologic disease
Chen et al. Age-related alterations in immune function and inflammation: focus on ischemic stroke
JP2013504603A5 (enExample)
Messora et al. Rosuvastatin promotes benefits on induced periodontitis in hypertensive rats
Thierry et al. NETs by-products and extracellular DNA may play a key role in COVID-19 pathogenesis: incidence on patient monitoring and therapy
Witowski et al. Role of mesothelial cell-derived granulocyte colony-stimulating factor in interleukin-17-induced neutrophil accumulation in the peritoneum
JP2010513308A (ja) 血管新生向性ペプチド
Saito et al. The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis
CN111182925A (zh) 阳离子核酸清除剂及其用途
Casilag et al. The biosynthetic monophosphoryl lipid A enhances the therapeutic outcome of antibiotic therapy in pneumococcal pneumonia
JP4744443B2 (ja) 毒素中和性ペプチドのスクリーニング方法とstx2阻害性ペプチド並びにベロ毒素中和剤
JP2007534772A5 (enExample)